Valuation
- Market cap
- 4,091,000
- Revenue TTM
- $7,190,000
- Net income TTM
- $-50,080,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -696.52%
- Debt to equity
- 0.00
Trading
- Volume
- 4,010,500
- Avg volume
- 1,494,488
- Day's range
- $0.07 – $0.13
- Shares out
- 21,043,000
- Stochastic %K
- 5%
- Beta
- 0.35
- Analysts
- Hold
- Price target
- $5.00
Company profile
T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- Phone
- 781 761 4646
- Website
- https://investors.t2biosystems.com
- Address
- 101 Hartwell Avenue, Lexington, United States
Latest news
No headlines yet.
